CAL
EVH icon

Capital Advisors Ltd’s Evolent Health EVH Stock Holding History

Capital Advisors Ltd’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-40
Closed – – 1420
2025
Q1 		$0 Buy
+40
New +$404 ﹤0.01% 1407
2024
Q2 		– Sell
-4
Closed – – 1460
2024
Q1 		$0 Hold
4
– – ﹤0.01% 1410
2023
Q4 		$0 Buy
+4
New +$113 ﹤0.01% 1345

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital Advisors Ltd's EVH Position: Q2 2025 in Review

Capital Advisors Ltd sold out of Evolent Health (EVH) in Q2 2025, closing a stake of 40 shares.

Capital Advisors Ltd first reported a position in EVH in Q4 2023 and held it in 3 quarters. The position peaked at $0 in Q1 2025. 220 funds tracked by Wall St. Rank hold EVH as of Q2 2025.

  • Capital Advisors Ltd reported no remaining Evolent Health position as of Q2 2025 after selling out during the quarter.
  • Capital Advisors Ltd sold 40 Evolent Health shares in Q2 2025.
  • Capital Advisors Ltd first reported a position in Evolent Health in Q4 2023 and held it in 3 quarters.
  • Capital Advisors Ltd's Evolent Health position peaked at $0 in Q1 2025.
  • 220 funds tracked by Wall St. Rank held Evolent Health as of Q2 2025.

Based on Capital Advisors Ltd's 13F filing for Q2 2025, filed 24 Jul 2025.